First-Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic NSCLC in CheckMate 9LA: 3-Year Clinical Update and Outcomes in Patients With Brain Metastases or Select Somatic Mutations – JOURNAL OF THORACIC ONCOLOGY

Paz-Ares, LG; Ciuleanu, TE; Cobo, M; Bennouna, J; Schenker, M; Cheng, Y; Juan-Vidal, O; Mizutani, H; Lingua, A; Reyes-Cosmelli, F; Reinmuth, N; Menezes, J; Jassem, J; Protsenko, S; Richardet, E; Felip, E; Feeney, K; Zurawski, B; Alexandru, A; Jimenez, ED; Dakhil, S; Lu, S; Reck, M; John, T; Hu, N; Zhang, XQ; Sylvester, J; Eccles, LJ; Grootendorst, DJ; Balli, D; Neely, J; Carbone, DP – 2023 – 10.1016/j.jtho.2022.10.014